exhibit_c_Responder Additional Proposed Products_0.xlsx

This is an Exhibit C form for the MMCAP Infuse program administered by the Minnesota Department of Administration, Office of State Procurement, designed to allow responders to propose additional pharmaceutical products beyond those initially bid. The form requests detailed product information including National Drug Code (NDC), SKU, UPC, generic and trade descriptions, strength, dosage form, packaging configuration, and additional specifications such as flavor or container type. Responders must complete company identification and address information at the top of the form and provide a comprehensive product listing with all required data fields populated accurately, particularly ensuring NDC numbers retain all leading zeroes. The contract period runs from July 1, 2022, through June 30, 2023.

Pricing submissions require specification of bid type (FP, NF30, NF60, NF90, or WAC-based pricing), WAC price, and proposed contract price, each calculated to two decimal points and based on the saleable unit rather than individual unit pricing. An administrative fee of three percent applies to all proposed products. The form serves as the mechanism for vendors to expand their product offerings under the MMCAP Infuse framework, with the state administrative reference number (MMSR) designated for tracking purposes. No specific set-aside information, incumbent details, or funding sources are indicated on this exhibit form, as it functions primarily as a product submission template within an established state pharmaceutical purchasing program.